These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 24960289

  • 1. Impact of rheumatoid arthritis in Turkey: a questionnaire study.
    Direskeneli H, Akkoç N, Bes C, Cakir N, Cefle A, Cobankara V, Dalkilic E, Dinc A, Ertenli I, Gul A, Hamuryudan V, Inanc M, Kalyoncu U, Karaaslan Y, Kasifoglu T, Keser G, Keskin G, Kisacik B, Kiraz S, Masatlioglu S, Onat AM, Ozbek S, Ozturk MA, Pamuk ON, Pay S, Pirildar T, Sayarlioglu M, Senel S, Senturk T, Tasan D, Terzioglu E, Yazici A, Yucel E.
    Clin Exp Rheumatol; 2014; 32(4):477-83. PubMed ID: 24960289
    [Abstract] [Full Text] [Related]

  • 2. Perceptions of methotrexate use in rheumatoid arthritis by rheumatologists and their patients: an Australian survey study.
    Nash P, Nicholls D.
    Int J Rheum Dis; 2013 Dec; 16(6):652-61. PubMed ID: 24382276
    [Abstract] [Full Text] [Related]

  • 3. Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis.
    Schulze-Koops H, Giacomelli R, Samborski W, Rednic S, Herold M, Yao R, Govoni M, Vastesaeger N, Weng HH.
    Clin Exp Rheumatol; 2015 Dec; 33(2):201-8. PubMed ID: 25664404
    [Abstract] [Full Text] [Related]

  • 4. Understanding the patient perspective - results of the Rheumatoid Arthritis: Insights, Strategies & Expectations (RAISE) patient needs survey.
    McInnes IB, Combe B, Burmester G.
    Clin Exp Rheumatol; 2013 Dec; 31(3):350-7. PubMed ID: 23406685
    [Abstract] [Full Text] [Related]

  • 5. Physician Preferences and Variations in Prescription of Biologic Drugs for Rheumatoid Arthritis: A Register-Based Study of 4,010 Patients in Sweden.
    Kalkan A, Husberg M, Hallert E, Roback K, Thyberg I, Skogh T, Carlsson P.
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1679-85. PubMed ID: 26097219
    [Abstract] [Full Text] [Related]

  • 6. Impact of Etanercept Therapy on Disease Activity and Health-Related Quality of Life in Moderate Rheumatoid Arthritis Patients Population from a National British Observational Cohort.
    Kotak S, Mardekian J, Horowicz-Mehler N, Shah A, Burgess A, Kim J, Gemmen E, Boyd H, Koenig A.
    Value Health; 2015 Sep; 18(6):817-23. PubMed ID: 26409609
    [Abstract] [Full Text] [Related]

  • 7. Depression is improved when low-dose tacrolimus is given to rheumatoid arthritis patients showing an inadequate response to biologic agents.
    Miwa Y, Hosaka M, Ohtsuka K, Sato M, Takahashi R, Wakabayashi K, Odai T, Yajima N, Kasama T.
    Mod Rheumatol; 2013 Sep; 23(5):920-4. PubMed ID: 22990336
    [Abstract] [Full Text] [Related]

  • 8. Advance and unmet need of health care for patients with rheumatoid arthritis in the German population--results from the German Rheumatoid Arthritis Population Survey (GRAPS).
    Westhoff G, Schneider M, Raspe H, Zeidler H, Runge C, Volmer T, Zink A.
    Rheumatology (Oxford); 2009 Jun; 48(6):650-7. PubMed ID: 19321515
    [Abstract] [Full Text] [Related]

  • 9. Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: results of a maximum difference scaling experiment.
    van Hulst LT, Kievit W, van Bommel R, van Riel PL, Fraenkel L.
    Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1407-14. PubMed ID: 21748861
    [Abstract] [Full Text] [Related]

  • 10. Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists.
    van Overbeeke E, De Beleyr B, de Hoon J, Westhovens R, Huys I.
    BioDrugs; 2017 Oct; 31(5):447-459. PubMed ID: 28929342
    [Abstract] [Full Text] [Related]

  • 11. Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study.
    Giacomelli R, Gorla R, Trotta F, Tirri R, Grassi W, Bazzichi L, Galeazzi M, Matucci-Cerinic M, Scarpa R, Cantini F, Gerli R, Lapadula G, Sinigaglia L, Ferraccioli G, Olivieri I, Ruscitti P, Sarzi-Puttini P.
    Rheumatology (Oxford); 2015 May; 54(5):792-7. PubMed ID: 25288786
    [Abstract] [Full Text] [Related]

  • 12. Translation and validation of the Turkish language version of the Rheumatoid Arthritis Disease Activity Index-5.
    Sunar I, Yilmaz Tasdelen O, Garip Cimen Y, Bodur H.
    Int J Rheum Dis; 2017 Dec; 20(12):2012-2019. PubMed ID: 24725498
    [Abstract] [Full Text] [Related]

  • 13. Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study.
    Calvo-Alén J, Monteagudo I, Salvador G, Vázquez-Rodríguez TR, Tovar-Beltrán JV, Vela P, Maceiras F, Bustabad S, Román-Ivorra JA, Díaz-Miguel C, Rosas J, Raya E, Carmona L, Cea-Calvo L, Arteaga MJ, Fernández S, Marras C.
    Clin Exp Rheumatol; 2017 Dec; 35(3):423-430. PubMed ID: 28032846
    [Abstract] [Full Text] [Related]

  • 14. Direct and indirect healthcare costs of rheumatoid arthritis patients in Turkey.
    Hamuryudan V, Direskeneli H, Ertenli I, Inanc M, Karaaslan Y, Oksel F, Ozbek S, Pay S, Terzioglu E, Balkan Tezer D, Hacibedel B, Akkoc N.
    Clin Exp Rheumatol; 2016 Dec; 34(6):1033-1037. PubMed ID: 27749224
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB, von Kempis J, Haile SR, Schiff MH.
    Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
    [Abstract] [Full Text] [Related]

  • 16. Health outcomes and unmet needs in patients with long-standing rheumatoid arthritis attending tertiary care in Greece: a cohort study.
    Boumpas DT, Sidiropoulos P, Settas L, Szczypa P, Tsekouras V, Hernandez Daly AC.
    Health Qual Life Outcomes; 2019 Apr 29; 17(1):73. PubMed ID: 31036012
    [Abstract] [Full Text] [Related]

  • 17. Effect of early treatment on physical function in daily management of rheumatoid arthritis: a 5-year longitudinal study of rheumatoid arthritis patients in the National Database of Rheumatic Diseases in Japan.
    Hirata A, Suenaga Y, Miyamura T, Matsui T, Tohma S, Suematsu E, Ohnaka K, Takayanagi R.
    Int J Rheum Dis; 2018 Apr 29; 21(4):828-835. PubMed ID: 27126059
    [Abstract] [Full Text] [Related]

  • 18. Benefit of biologics initiation in moderate versus severe rheumatoid arthritis: evidence from a United States registry.
    Kavanaugh A, Keystone E, Greenberg JD, Reed GW, Griffith JM, Friedman AW, Saunders KC, Ganguli A.
    Rheumatology (Oxford); 2017 Jul 01; 56(7):1095-1101. PubMed ID: 28340006
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study.
    Addimanda O, Marino M, Farina I, Trevisani M, Arrigoni E, Lumetti F, Crescentini F, Sambo P, Bezzi A, Bruschi M, Santilli D, Reta M, Bosi S, Delsante G, Girelli F, Montaguti L, Meliconi R, Sebastiani M, Ferri C, Malavolta N, Govoni M, Trombetti S, De Palma R, Salvarani C.
    Clin Exp Rheumatol; 2017 Jul 01; 35(2):201-208. PubMed ID: 28134078
    [Abstract] [Full Text] [Related]

  • 20. The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritis.
    Feuchtenberger M, Kleinert S, Scharbatke EC, Gnann H, Behrens F, Wittig BM, Greger G, Tony HP.
    Clin Exp Rheumatol; 2015 Jul 01; 33(3):321-9. PubMed ID: 25897681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.